Targeted overexpression of Dkk1 in osteoblasts reduces bone mass but does not impair the anabolic response to intermittent PTH treatment in mice

By Yao Gang-Qing  

Journal of Bone and Mineral Metabolism, Vol. 29, Iss. 2, 2011-03 ,pp. : 141-148

Springer Publishing Company

Access to resources Recommend Favorite

Anabolic Agents and Bone Quality

By Sibai Tarek  

Clinical Orthopaedics and Related Research, Vol. 469, Iss. 8, 2011-08 ,pp. : 2215-2224

Springer Publishing Company

Access to resources Recommend Favorite

Strong effect of PTH (1-34) on regenerating bone: A time sequence study in rats

By Skripitz Ralf   Andreassen Troels T   Aspenberg Per  

Acta Orthopaedica Scandinavica, Vol. 71, Iss. 6, 2000-12 ,pp. : 619-624

Informa Healthcare

Access to resources Recommend Favorite

Expression of bone type 1 PTH receptor in rats with chronic renal failure

By Kuwahara Michio   Inoshita Seiji   Nakano Yukiko   Terada Yoshio   Takano Yoshiro   Sasaki Sei  

Clinical and Experimental Nephrology, Vol. 11, Iss. 1, 2007-03 ,pp. : 34-40

Springer Publishing Company

Access to resources Recommend Favorite

The effect of simvastatin on serum cytokine levels and bone metabolism in postmenopausal subjects: negative correlation between TNF-α and anabolic bone parameters

By Tikiz Canan   Ünlü Zeliha   Tikiz Hakan   Ay Kamuran   Angın Aclan   Onur Ece   Var Ahmet   Tüzün ÇiĞdem  

Journal of Bone and Mineral Metabolism, Vol. 22, Iss. 4, 2004-07 ,pp. : 365-371

Springer Publishing Company

Access to resources Recommend Favorite